Psychoactive prescription drug use and misuse in patients on opioid agonist treatment
In this population, prescription drug misuse primarily included opioid analgesics and increasingly pregabalin. Given the risk of opioid overdose, access to take-home naloxone should be further improved.
Authors
- Joëlle Micallef (ORCID: https://orcid.org/0000-0002-7172-7835)
- Élisabeth Frauger (ORCID: https://orcid.org/0000-0003-1879-5625)
- Thomas Soeiro (ORCID: https://orcid.org/0000-0003-2604-9673)
- Maryse Lapeyre‐Mestre (ORCID: https://orcid.org/0000-0002-5494-5873)
- Clémence Lacroix (ORCID: https://orcid.org/0000-0002-6857-4698)
- Élisabeth Jouve (ORCID: https://orcid.org/0000-0002-4873-6522)
Institutions
- Center for Drug Evaluation and Research (US)
- Inserm (FR)
- Université Fédérale de Toulouse Midi-Pyrénées (FR)
- Aix-Marseille Université (FR)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2025-10-16
- DOI
- https://doi.org/10.1002/bcp.70306
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00